{"id":517,"date":"2024-04-30T10:05:43","date_gmt":"2024-04-30T10:05:43","guid":{"rendered":"https:\/\/saneuro-dz.com\/?page_id=517"},"modified":"2024-04-30T10:23:37","modified_gmt":"2024-04-30T10:23:37","slug":"liste-des-eposters","status":"publish","type":"page","link":"https:\/\/saneuro-dz.com\/index.php\/liste-des-eposters\/","title":{"rendered":"Liste des eposters"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><strong><span style=\"font-size:19px;color:red;\">C\u00e9phal\u00e9es et algies de la_face<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P1 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"> Migraine h\u00e9mipl\u00e9gique dans le cadre d&rsquo;un syndrome d&rsquo;Ehler Danlos \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Benaggoun &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">EPH Slimane Amirat Barika Batna<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\"> <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> D\u00e9g\u00e9n\u00e9rative<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;font-size:11.0pt;font-family:'Calibri',sans-serif;text-indent:3.75pt;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P2 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Hydroc\u00e9phalie \u00e0 pression normale : A propos d\u2019une s\u00e9rie de 13 patients<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\"> D. Moualek, <\/span><\/strong><span style=\"font-size:12px;color:black;\">A. Saadi, B. Merrouche, L. Mahfouf, L. Ali pacha. &#8211; CHU Mustapha <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P3 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">In vitro evaluation of the neuroprotective potential of peach fruit extracts against <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">\u03b2<\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">-Amyloid and <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">\u03b1<\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">-synuclein neurototoxicity<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Mokrani &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Universit\u00e9 de B\u00e9jaia<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P4 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Int\u00e9r\u00eat des biomarqueurs dans les formes pr\u00e9symptomatiques de la maladie d\u2019Alzheimer<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Younsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">F. Mostefaoui, L. Ali Pacha &#8211; CHU mustapha &#8211; Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P5 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La maladie de Brait-Fahn-Schwarz : une association rare d\u2019une SLA et d\u2019une maladie de parkinson<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Nacer Khodja, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Tibouche,  F. Ysmail Dahlouk, H. Leklou &#8211; CHU BEO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P6 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les formes langagi\u00e8res de maladie d&rsquo;Alzheimer: int\u00e9r\u00eat des biomarqueurs.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Amalou,<\/span><\/strong> <span style=\"font-size:12px;color:black;\">S Kesraoui<\/span><strong><span style=\"font-size:13px;color:#002060;\"> &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service neurologie CHU Frantz Fanon BLIDA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P7 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neuropathie h\u00e9r\u00e9ditaire optique de Leber et tabac : Quel lien ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">T. Sari, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Belarbi ,  F. Leboukh &#8211; EHS Ali Ait Idir <\/span><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;font-size:11.0pt;font-family:'Calibri',sans-serif;\"><strong><span style=\"font-size:19px;color:black;\">P8 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Syndrome SLA like associ\u00e9 \u00e0 un syndrome d&rsquo;Allgrove<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M.  Kohil,<\/span><\/strong><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\"> <\/span><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\">S. Aouadj,  H. Yakhlef &#8211; <\/span><strong><span style=\"font-size:13px;color:#002060;\"> <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Batna<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\">Douleur<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P9 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">MEOPA et anxiolyse chez l\u2019enfant : r\u00e8gles de bonne pratique en p\u00e9dodontie.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">C. Kheraifia, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Issad Hassani Beni messous<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P10 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Sp\u00e9cificit\u00e9s de la douleur chez l\u2019enfant.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M.R.  Khelouf &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Centre national d\u2019expertise m\u00e9dicale du personnel navigant Ain naadja <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\"> <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> \u00c9pilepsie<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P11 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Attention et m\u00e9moire de travail chez des enfants \u00e9pileptiques (\u00e9tude de cas)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Djemmad, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Universit\u00e9 de Ghardaia<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P12 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Epilepsie et lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9 chez une fille \u00e2g\u00e9e de 11 ans<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Boufres &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU DE Constantine<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P13 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Epilepsie r\u00e9v\u00e9lant une Scl\u00e9rose en Plaques<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Mezdad, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHS Ali Ait Idir<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P14 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Epilepsie vasculaire \u00ab Facteurs pr\u00e9dictifs \u00bb<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N.H. Bounezra, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha &#8211; CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P15 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Implication probable du sild\u00e9nafil dans la survenue de crises convulsives et importance de l&rsquo;analyse toxicologique : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A.L. Ikhenazene, <\/span><\/strong><span style=\"font-size:12px;color:black;\">L. Fadel , K. Sobhi &#8211; H\u00f4pital Ain Naadja<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P16 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">l\u2019\u00e9pilepsie en milieu p\u00e9dopsychiatrique : a propos d\u2019une \u00e9tude au niveau du service de p\u00e9dopsychiatrie d\u2019Oran<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Al Shammari &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHS psychiatrique sidi chami Oran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P17 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Le syndrome de Sturge Weber Krabbe ,  \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">L. Kadri, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Kediha MI Saadi AK Ali Pacha L &#8211;  CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P18 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Le syndrome de Sturge-Weber-Krabbe<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Chouali &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">EPH El Amir Abd El Kader Besbes El Taref<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\"> <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Neuro g\u00e9n\u00e9tique<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P19 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Diagnostic mol\u00e9culaire des maladies neurologiques : Int\u00e9r\u00eat de l\u2019utilisation du s\u00e9quen\u00e7age de l&rsquo;exome en contexte clinique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Messaoud Khelifi, <\/span><\/strong><span style=\"font-size:12px;color:black;\"> Laboratoire de Biologie Cellulaire et Mol\u00e9culaire, <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P20 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La surdi-c\u00e9cit\u00e9 familiale : et si c\u2019\u00e9tait un syndrome de USHER<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Boughoufala, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha service de neurologie &#8211; Chu Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P21 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Profil clinique de la neurofibromatose type 1 chez l\u2019enfant : a propos de 38 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Melzi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">A. Ladjouze, K. Boulesnane , R. Aboura, N. Bouhafs, Z. Bouzerar &#8211; H\u00f4pital Mohamed Lamine Debaghine CHU Bab El Oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:.0001pt;margin-left:0cm;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Neuro_infectieux<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P22 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Infection virale chronique par le virus de l\u2019h\u00e9patite B r\u00e9v\u00e9l\u00e9e Par un syndrome de Guillain Barr\u00e9 (association ou complication ? description d\u2019un cas clinique)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">W. Boukrouma &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Cit\u00e9 641 loge logement Skikda Alg\u00e9rie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P23 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Manifestations neurologiques du VIH: Variabilit\u00e9 clinique et \u00e9volutive<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Boughoufala, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. I. Kediha, L. Ali Pacha &#8211; Chu Mustapha <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P24 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Paralysie isolee du nerf grand hypoglosse &#8230;. Quand \u00e9voquer l\u2019origine virale ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Bounezra, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. I. Kediha, L. Ali Pacha &#8211; Chu Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Neuro_oncologie<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P25 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Effet de l\u2019Everolimus dans la Scl\u00e9rose Tubereuse de Bourneville chez l\u2019enfant : \u00e0 propos de 2 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. melzi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">A. Ladjouze, R. Aboura, N. Bouhafs, K. Boulesnane , Z. Bouzerar .  H\u00f4pital Mohamed Lamine Debaghine CHU Bab El Oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P26 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">\u00c9valuation des extraits de fruits de p\u00eache comme agents anticanc\u00e9reux sur les cellules u87 responsables de glioblastome humain<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. MOKRANI &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Universit\u00e9 de B\u00e9jaia<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P27 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Il y a un hic dans cette enc\u00e9phalite : Exploration d&rsquo;un dilemme diagnostique.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Younsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. I. Kediha,  D. Moualek, L. Ali Pacha &#8211; Chu Mustapha  <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P28 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neuromy\u00e9lite optique para n\u00e9oplasique: association fortuite ou cons\u00e9quence?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. AMALOU, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S Kesraoui &#8211; Service neurologie CHU Frantz Fanon Blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P29 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neuropathies optiques non inflammatoires : Une s\u00e9rie hospitali\u00e8re<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">Khedimallah Khaoula, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Pr Kediha Pr Ali pacha \u2013 CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\">Neuro_ophtalmologie<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P30 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">N\u00e9vrite optique en p\u00e9diatrie : Quelles \u00e9tiologies ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">melzi souhila, <\/span><\/strong><span style=\"font-size:12px;color:black;\">A Ladjouze, R. Aboura, N.Bouhafs, K.Boulesnane, Z.Bouzerar &#8211; H\u00f4pital Mohamed Lamine Debaghine CHU Bab El Oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P31 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Notre alimentation affecte-t-elle notre vue?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A.I. khira &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">H\u00f4pital central de l&rsquo;arm\u00e9e<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P32 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neuropathie optique r\u00e9trobulbaire r\u00e9v\u00e9lant une maladie c\u0153liaque chez l\u2019adulte, A propos de deux cas.<\/span><\/strong><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:.0001pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:13px;color:#002060;\">S. Nekrouf<\/span><\/strong><span style=\"font-size:12px;color:black;\">, T. Belakhdar, D. Bentabak, S. Bouchtara, D. Badsi. <\/span><span style=\"font-size:12px;color:black;\">1-Service de neurologie m\u00e9dicale &#8211; EHU d\u2019Oran Alg\u00e9rie  2-Facult\u00e9 de m\u00e9decine d\u2019Oran1.<\/span><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:.0001pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\"> <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Neuromusculaire<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P33 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"> Association myasth\u00e9nie auto-immune et dermatomyosite<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Ait Ouarab, M. maamar, Y. Mersel. Pr Leklou <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU BEO <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:.0001pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P34 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Facial baroparesis: une capricieuse paralysie faciale p\u00e9riph\u00e9rique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Bahmani, <\/span><\/strong><span style=\"font-size:12px;color:black;\">F. Bemmoussat &#8211; service de m\u00e9decine interne HMRUO \u2013 N. Oudrer &#8211; service de neurologie CHUOran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\">Aidi Ahmed &#8211; service de neurologie CHUOran &#8211; Chentouf Amina- service de neurologie CHUOran\u00a0\u00bb<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:12px;color:black;\"> <\/span><\/strong><strong><span style=\"font-size:19px;color:black;\">P35 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les syndromes myasth\u00e9niques cong\u00e9nitaux avec anomalies cin\u00e9tiques du r\u00e9cepteur \u00e0 l\u2019ac\u00e9tylcholine<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. I. Kediha, <\/span><\/strong><span style=\"font-size:12px;color:black;\">F. Mostefaoui, D. Sternberg, B. Eymard, L. Ali Pacha- CHU Mustapha Bacha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P36 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"><u>Moderate <\/u>phenotype of a congenital myasthenic syndrome caused by mutation of the COL13A1 gene: a case report<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. I. Kediha, <\/span><\/strong><span style=\"font-size:12px;color:black;\">F. Mostefaoui, D. Sternberg, B. Eymard, L. Ali Pacha- CHU Mustapha Bacha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P37 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Myopathie retractile : est-ce une collag\u00e9nose (a propos d\u2019un cas)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">K. Lahouassa, <\/span><\/strong><span style=\"font-size:12px;color:black;\">N. Kassouri, R. Hadjou, W. Amer el khedoud &#8211; ALGER<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P38 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Myopathie r\u00e9tractile s\u00e9v\u00e8re avec hyperlaxit\u00e9 distale.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Chabane, <\/span><\/strong><span style=\"font-size:12px;color:black;\"> CHU BEO Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P39 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neuropathies motrices multifocales : les jalons cliniques et para cliniques du bon diagnostic<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M.I. Kediha, <\/span><\/strong><span style=\"font-size:12px;color:black;\">F. Mostefaoui, S. Boumali L. Ali Pacha &#8211; CHU Mustapha BachA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P40 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Prise en charge des maladies neurologiques inflammatoires (SNC ,SNP)par \u00e9changes plasmatiques : Exp\u00e9rience du service de Neurologie EHUO (2015-2022)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Badsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P41 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Une myasth\u00e9nie auto-immune associ\u00e9e \u00e0 un cancer de la prostate et \u00e0 des AC anti titine et anti RAch positifs : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Ouali, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mohamed Lamine debaghine ex maillot baba El oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P42 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Une myasth\u00e9nie auto-immune paran\u00e9oplasique tardive \u00e0 anti titine positive : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Fedghouche &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Bab El Oued Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Neurop\u00e9diatrie<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P43 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"> Le Syndrome d\u2019Aicardie- Gouti\u00e8res: Etude clinique et g\u00e9n\u00e9tique de 3 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Moualek, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Saadi A, Kassouri , Amer El Khedoud W, Colleaux L, Ali Pacha L &#8211; CHU Mustapha Place du 1er Mai<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P44 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Ag\u00e9n\u00e9sie du corps calleux : A propos de 08 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Ighmer, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi, C. Mouhoubi, R. Tounsi, Z. Bouzerar &#8211; Centre hospitalo-universitaire BEO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P45 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Hypertension intracr\u00e2nienne idiopathique chez l\u2019enfant, \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. BAHLALI &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHS Ben Aknoun<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P46 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Hypertension Intracranienne idiopathique de l\u2019enfant<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">C. Mouhoubi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi, A. Ladjouze, K. Boulesnane, z. Bouzerar &#8211; CHU BEO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P47 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La maladie de Charcot Marie Tooth chez l`enfant : il faut y penser !<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">Ben m&rsquo;rad Asma, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi, A.Ladjouze, R.Aboura, N.bouhafs, K. Boulesnane, Z.Bouzerar &#8211; CHU BEO alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P48 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La PESS, \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">C. Lichani &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de neurologie CHU Blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P49 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les ceroides lipofuschinoses: Etude clinique et g\u00e9n\u00e9tique de 2 familles<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Moualek, <\/span><\/strong><span style=\"font-size:12px;color:black;\">A. Saadi, F. Magrinelli, H. Houlden, L. Ali Pacha. &#8211; CHU Mustapha <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P50 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les enc\u00e9phalites aigues de l\u2019enfant : \u00e0 propos de 15 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">oudaoud faiza, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi, A. Ladjouze, R. Aboura, K. Boulesnane, Z. Bouzerar \u2013 CHU BEO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P51 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les enc\u00e9phalites aigues de l\u2019enfant : \u00e0 propos de 17 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">F. Oudaoud, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi, A. Ladjouze, R. Aboura, K. Boulsenane, Z. Bouzerar   &#8211; CHU BEO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P52 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Myasth\u00e9nie auto-immune infantile (03 cas)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Kohil,<\/span><\/strong><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\"> <\/span><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\">S. Aouadj , H. Yakhlef  &#8211; <\/span><strong><span style=\"font-size:13px;color:#002060;\"> <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Batna<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P53 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neuromy\u00e9lite optique de l&rsquo;enfant \u00e0 propos de 4 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Kohil,<\/span><\/strong><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\"> <\/span><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\">S. Aouadj et H. Yakhlef  &#8211; <\/span><strong><span style=\"font-size:13px;color:#002060;\"> <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Batna<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P54 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">N\u00e9vralgie amyotrophiante ( Syndrome de Parsonge Turner ) chez un enfant<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Branki, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de neurologie CHU BEO <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P55 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Prise en charge des convulsions aux urgences p\u00e9diatriques<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Merdoud, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S.Melzi, K.Zigha, A.Ladjouze, R.Aboura, K,Boulesnane, L,Mebrouki, Z,Bouzerar &#8211; Babeloued, alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P56 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Profil \u00e9tiologique et \u00e9volutif du Syndrome de West : \u00e0 propos de 23 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Gouala, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi , A.Ladjouze, R.Aboura, N.Bouhafs, K.Boulesnane, Z.Bouzerar &#8211; Service de p\u00e9diatrie- Chu Beb El oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P57 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Scl\u00e9rose en plaques et syndrome de Bardet-Bidel<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Djaafri, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de neurologie CHU Mustapha Bacha Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P58 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Scl\u00e9rose tub\u00e9reuse de Bourneville: \u00e0 propos de 10 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Tounsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S.Melzi, R. Aboura, A.Ladjouze , N.Bouhafs ,K.Boulesnane Z. Bouzerar. &#8211; CHU Beb Eloued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P59 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Syndrome d\u2019enc\u00e9phalopathie post\u00e9rieure r\u00e9versible chez l\u2019enfant : \u00e0 propos de deux cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">H. Zeroukhi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Melzi, A. Ladjouze, R. Aboura, K. Boulesnane, N. Bouhafs, Z. Bouzerar &#8211; CHU Bab El Oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Parkinson et autres mouvements anormaux<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P60 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Maladie de Parkinson de d\u00e9but pr\u00e9coce et juv\u00e9nile : Etude d\u2019une s\u00e9rie de 131 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Benmahdjoub, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Kesraoui, A. Benmahdjoub, K. Senouci, O. Bouabdallah \u2013 blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\"> <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P61 &#8211; Illustration d\u2019un d\u00e9clin d\u2019efficacit\u00e9 de la neurotoxine botulique ayant suivi une r\u00e9ponse spectaculaire.<\/span><\/strong><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:.0001pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:13px;color:#002060;\">M.C. Chekkour<\/span><\/strong><span style=\"font-size:12px;color:black;\">, H. Zobiri &#8211; Neurologie, CHU S\u00e9tif<\/span><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:.0001pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Pathologie_inflammatoire<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P62 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"> La scl\u00e9rose en plaques dans sa forme pseudo-leucodystrophique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">Y.  koubci, <\/span><\/strong><span style=\"font-size:12px;color:black;\">HCA <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P63 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Apport de la bioth\u00e9rapie dans la prise en charge de la Scl\u00e9rose en plaques et des troubles du spectre de neuromy\u00e9lite optique- Etude d&rsquo;une s\u00e9rie<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Bentabak, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Oran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P64 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Aspect inhabituel de l\u2019imagerie au cours d\u2019un Neurolupus<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N.H Bounezra &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P65- <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Association entre maladie parodontale et la maladie d\u2019alzheimer<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. BEGGAH<\/span><\/strong><strong><span style=\"font-size:12px;color:#002060;\">, <\/span><\/strong><span style=\"font-size:12px;color:black;\">MAHFOUD.A *,  MEDDAD.M* &#8211; CHU Mustapha. service de parodontologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P66 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Atteinte du c\u00f4ne terminal, forme atypique de scl\u00e9rose en plaques : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">F. Bensid\u2013 <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P67 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Enc\u00e9phalite auto-immune \u00e0 anticorps anti-r\u00e9cepteur au GABA de type B : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Derder, <\/span><\/strong><span style=\"font-size:12px;color:black;\">W. Benzaghou, H. Bouzenada &#8211; HCA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P68 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Enc\u00e9phalite avec c\u00e9cit\u00e9 et surdit\u00e9: \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Arnane, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P69 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Forme inflammatoire de l\u2019angiopathie amylo\u00efde c\u00e9r\u00e9brale : A propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Djabou, <\/span><\/strong><span style=\"font-size:12px;color:black;\">HCA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P70 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Formes pseudo chirurgicales des pathologies inflammatoires du syst\u00e8me nerveux central :\u00e0 propos de deux cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">F. Bensid, M.I. Kediha, L. Ali Pacha <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service neurologie CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P71 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">L\u2019enc\u00e9phalopathie de Gayet-Wernicke \u00c0 propos de deux cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">C. Lichani,<\/span><\/strong><span style=\"font-size:12px;color:black;\"> R. Drai, S. Kesraoui &#8211; Service de neurologie CHU Blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P72 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La migraine dans la scl\u00e9rose en plaques : signe atypique ? signe prodromal ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M.I Kediha, <\/span><\/strong><span style=\"font-size:12px;color:black;\">D. Moualek, S. Hantala, L. Ali Pacha &#8211; CHU Mustapha Bacha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P73 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La scl\u00e9rose en plaques dans sa forme tardive : \u00e0 propos d\u2019une s\u00e9rie hospitali\u00e8re<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Younsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M.I. Kediha, D. Moualek S. Boumali, L. Ali Pacha &#8211; Chu Mustapha Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P74 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les manifestations immunologiques rares du COVID-19 : a propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A.I. khira &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">H\u00f4pital central de l&rsquo;arm\u00e9e<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P75 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les particularit\u00e9s cliniques biologiques radiologiques et \u00e9volutives des mogopathies : s\u00e9rie hospitali\u00e8re<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Bouakaz &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">service de neurologie CHU MUSTAPHA <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P76 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Manifestations neurologiques de la sarco\u00efdose \u00c0 propos d&rsquo;une s\u00e9rie de 14 cas.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Badsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P77- <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neurom\u00e9lite optique (NMO) positive pour AQP4 associ\u00e9e \u00e0 un Lupus Eryth\u00e9mateux Diss\u00e9min\u00e9 (LED), Syndrome de Gougerot-Sj\u00f6gren (SGS) et Cirhose Biliaire Primitive (CBP) : \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Chabane &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU BEO Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P78 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neurosarco\u00efdose : A propos de de huit cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Hantala &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU MUSTAPHA Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P79 &#8211; <\/span>Nevrite optique a AC antimog post infectieuse<\/strong><strong><span style=\"font-size:16px;color:black;\"><br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">K. Khedimallah, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Dr IF Bouakaz Pr L Ali pacha &#8211; CHU MUSTAPHA Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P80 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">PRNA A RECHUTE OU PRNC : \u00e9tude de nos cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Boughoufala, &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU MUSTAPHA Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P81 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Que cache une premi\u00e8re crise convulsive?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Houari, <\/span><\/strong><span style=\"font-size:12px;color:black;\">ALGER &#8211; EHS Ali Ait Idir<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P82 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">SEP ou SEC ? peut-on faire la diff\u00e9rence ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Hantala &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU MUSTAPHA Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P83 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Syndrome de Gougerot-Sj\u00f6gren r\u00e9v\u00e9l\u00e9 par un tableau enc\u00e9phalitique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">Y. koubci &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">HCA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P84 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Syndrome de Guillain barr\u00e9 associ\u00e9e \u00e0 une tuberculose extra-pulmonaire : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Ouali, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Chu Mohamed Lamine debaghine ex maillot baby El oued &#8211; Chu maillot<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P85 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Traitement de la scl\u00e9rose en plaque p\u00e9diatrique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Hantala &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha Alger<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P86 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Troubles cognitifs inauguraux dans la scl\u00e9rose en plaques: ou en est on?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Amalou, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service neurologie CHU FRANTZ FANON BLIDA  <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P87 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Une dystonie paroxystique r\u00e9v\u00e9lant une Scl\u00e9rose en plaques : \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Drias, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Tibouche, F. Ysmail Dahlouk, H. Leklou S Kesraoui- CHU BEO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P88 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Une mogopathie d\u2019\u00e9volution fatale&#8230; \u00c0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">C. Lichani &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de neurologie CHU Blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> Vasculaire<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P89 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Accident vasculaire c\u00e9r\u00e9bral isch\u00e9mique chez un patient atteint de polykystose r\u00e9nale familiale : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Djabou &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">HCA <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P90 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Accident vasculaire c\u00e9r\u00e9brale h\u00e9morragique sur une maladie de MOYA MOYA : A propos d\u2019une observation<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Benmahdjoub, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Benmahdjoub ,  S. kesraoui, M. Djelti, K. Senouci &#8211; CHU BLIDA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P91 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Hypertension intracr\u00e2nienne avec polyendocrinopathies: \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Arnane, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P92 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Interet du POCAS dans la d\u00e9tection du vasospasme chez les AVC h\u00e9morragique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Benmoussa, <\/span><\/strong><span style=\"font-size:12px;color:black;\">D. Bentabak, D. Badsi EHU Oran HU ORAN<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P93 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Ischemie c\u00e9r\u00e9brale r\u00e9velatrice d&rsquo;un an\u00e9verysme g\u00e9ant \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">BADSI douniazede, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P94 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">l\u2019accident vasculaire c\u00e9r\u00e9bral isch\u00e9mique au cours du syndrome d\u2019hyperstimulation ovarienne compliquant une proc\u00e9dure de PMA, \u00e0 propos d&rsquo;un cas.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">K. Senouci, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Benmahdjoub, A. Benmahdjoub, M. Djelti, S. Kesraoui &#8211; Service de Neurologie, CHU de Blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P95 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La maladie de Moya Moya : Une cause rare d\u2019AVC du sujet jeune<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Moualek, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Younsi, C. Hantala, L. Ali Pacha &#8211; CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P96 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les autres causes rares des accidents vasculaires cerebraux<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A.I. khira &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">H\u00f4pital central de l&rsquo;arm\u00e9e<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P97 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les causes h\u00e9matologiques des thromboses veineuses c\u00e9r\u00e9brales.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">O. Bouabdallah, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service De Neurologie CHU Frantz Fanon Blida  <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P98 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les thromboses veineuses c\u00e9r\u00e9brales Etude d\u2019une s\u00e9rie de 37 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Moualek, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Younsi, C. Hantala, L. Ali Pacha &#8211; CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P99 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">L&rsquo;infartus bithamalique, affection rare et trompeuse. \u00c2 propos d\u2019un cas.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">R. Derder, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Chemli , H. Bouzenada &#8211; HCA<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P100 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Maladie de Moya Moya r\u00e9v\u00e9l\u00e9 par un AVC isch\u00e9mique : \u00e0 propos d&rsquo;un cas .<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">Bougheziou Radhia &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU saadna abdanour S\u00e9tif<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P101 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Profil \u00e9pid\u00e9miologique, clinique et \u00e9volutif des AVC h\u00e9morragiques :Exp\u00e9rience du service de Neurologie \u00e0 l\u2019EHU d\u2019ORAN (2015-2021)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. BADSI &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P102 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">T\u00e9l\u00e9m\u00e9decine et AVC :Oran-Touggourt: exp\u00e9rience du service de neurologie EHU.O<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. BADSI &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P103 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Thrombolyse IV au-del\u00e0 de la fen\u00eatre th\u00e9rapeutique :Int\u00e9r\u00eat de la perfusion c\u00e9r\u00e9brale.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. BADSI, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P104 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Thrombose veineuse c\u00e9r\u00e9brale et prise de cr\u00e9atine \u00e0 but sportif : une association fortuite ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N.Cherifi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">chanderli M-Z &#8211; Ain Defla <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P105 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Thrombose veineuse c\u00e9r\u00e9brale r\u00e9sistante aux AVK r\u00e9v\u00e9lant une maladie c\u0153liaque, \u00e0 propos de deux cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">I. Khaled, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de neurologie Chu Setif<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P106 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Thromboses veineuses c\u00e9r\u00e9brales au cours de la grossesse : \u00c9tude de 18 cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">O. Bouabdallah, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service De Neurologie CHU Frantz Fanon Blida<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P107- <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Une thrombolyse d\u2019un AVC isch\u00e9mique r\u00e9alis\u00e9e \u00e0 48h entre le d\u00e9lire et la r\u00e9alit\u00e9 quelles perspectives ? (\u00e0 propos d&rsquo;un cas)<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Benmoussa, <\/span><\/strong><span style=\"font-size:12px;color:black;\">D. Bentabak, D. Badsi EHU Oran <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:red;\">Autres<\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\"> <\/span><\/strong><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P108 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"> Le Myelo-myelo complication rare d&rsquo;une carence en cuivre \u00e0 propos d&rsquo;un cas.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Badsi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie.<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P109- <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\"> Quels tests neuropsychologiques pour trouble cognitif en chirurgie coronarien ?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">K. Bendjoudi,<\/span><\/strong><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\"> K. Ghabouli, A. Dahoumen, W. Hafidi, R. Mehyaoui<br \/> CHU Mustapha EHS mohamed abderahmani cardiovasculaire EHS Dr Maouche Mohand Amoukrane<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P110 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">\u00ab\u00a0Parodontite et Parkinson : Un Regard Approfondi sur les Liens M\u00e9connus\u00a0\u00bb<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Mahfoud, <\/span><\/strong><span style=\"font-size:12px;color:black;\">D. Beggah,  M. Meddad &#8211; CHU MUSTAPHA service de parodontologie<\/span><\/p>\n<p style=\"margin-right:0cm;margin-left:0cm;font-size:16px;font-family:'Times New Roman',serif;margin:0cm;margin-bottom:.0001pt;background:white;\"><strong><span style=\"font-size:19px;font-family:'Calibri',sans-serif;color:black;\">P111 &#8211; <\/span><\/strong><strong><span style=\"font-family:'Calibri',sans-serif;color:black;\">Apport de l\u2019IRM c\u00e9r\u00e9brale dans la prise en charge diagnostique et th\u00e9rapeutique d\u2019un neurobe\u00e7het : \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;font-family:'Calibri',sans-serif;color:#002060;\">Y. Belkheir<\/span><\/strong><span style=\"font-family:'Century',serif;color:#1D2228;\">, <\/span><span style=\"font-size:12px;font-family:'Calibri',sans-serif;color:black;\">A. Bahmani, A. Chentouf, N. Oudrer &#8211; Service de Neurologie CHU Oran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\"> <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P112 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Convulsions d&rsquo;origine toxique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">Y.  Madaci, <\/span><\/strong><span style=\"font-size:12px;color:black;\">service de toxicologie CHU Bab El Oued<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P113 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Enc\u00e9phalite de Gayet et Wernicke: aspects cliniques et \u00e9tiologiques<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Ouafi, <\/span><\/strong><span style=\"font-size:12px;color:black;\">S. Amalou, O. Bouabdalah, S. Kesraoui &#8211; CHU Blida Frantz Fanon<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:.0001pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P114 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">h\u00e9t\u00e9rotopie gliale du cuir chevelu<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">A. Bahmani, <\/span><\/strong><span style=\"font-size:12px;color:black;\">F. Bemmoussat &#8211; service de m\u00e9decine interne HMRUO \u2013 N. Oudrer &#8211; service de neurologie CHUOran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><span style=\"font-size:12px;color:black;\">A. Aidi &#8211; service de neurologie CHUOran \u2013 A. Chentouf &#8211; service de neurologie CHUOran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P115- <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Hospitalisation \u00e0 domicile (HAD):AVC et autres pathologie neurologiques Experience du service de neurologie EHUO<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. BADSI, <\/span><\/strong><span style=\"font-size:12px;color:black;\">EHU Oran service de neurologie<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P116 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">L\u2019hypertension intracr\u00e2nienne idiopathique : A propos d\u2019une s\u00e9rie de 41 patients<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">D. Moualek, <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de Neurologie CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P117 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">La Polyth\u00e9rapie des anti\u00e9pileptiques ,  entre l&rsquo;\u00e9chec th\u00e9rapeutique et la toxicit\u00e9<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">L. Fadel, <\/span><\/strong><span style=\"font-size:12px;color:black;\">H\u00f4pital Central De L\u2019arm\u00e9e, Ain Naadja<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P118 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Le syndrome de la personne raide, \u00e0 propos d\u2019un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">L. Kadri, <\/span><\/strong><span style=\"font-size:12px;color:black;\"> F. Mostefaoui MI. Kediha , AK. Saadi, L. Ali Pacha \u2013 CHU MUSTAPHA<\/span><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;font-size:11.0pt;font-family:'Calibri',sans-serif;\"><strong><span style=\"font-size:19px;color:black;\">P119 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Les facteurs de risque des troubles cognitives en chirurgie cardiaque<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">K. Bendjoudi,<\/span><\/strong><span style=\"font-size:11px;font-family:'Verdana',sans-serif;color:black;\"> K. Ghabouli, A. Dahoumen, W. Hafidi, R. Mehyaoui<br \/> CHU Mustapha EHS mohamed abderahmani cardiovasculaire EHS Dr Maouche Mohand Amoukrane <\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P120 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Maladie de Marchiava Bignami: \u00e0 propos d&rsquo;un cas<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">S. Arnane, <\/span><\/strong><span style=\"font-size:12px;color:black;\">CHU Mustapha<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P121 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Neurological aspects of vitamin B12 deficiency: diagnosis and management.<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M.I. Kediha, <\/span><\/strong><span style=\"font-size:12px;color:black;\">M. Younsi, F. Mostefaoui, L. Ali Pacha &#8211; Chu Mustapha Bacha<\/span><\/p>\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:.0001pt;margin-left:0cm;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;background:white;\"><strong><span style=\"font-size:19px;color:black;\">P122 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">NMOSD : traitement des pouss\u00e9es<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N.Oudrer<\/span><\/strong><span style=\"font-size:12px;color:black;\">, A. Chentouf, A. Aidi  &#8211; Service de Neurologie CHU ORAN<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P123 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">NMOSD en Neuroradiologie : Quand y\u2019penser<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Oudrer, <\/span><\/strong><span style=\"font-size:12px;color:black;\">A. Chentouf, B. Abdelhamid<\/span><strong><span style=\"font-size:13px;color:#002060;\"> &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service de Neurologie CHU ORAN<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P124 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">NO cecitante post traumatique<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Oudrer &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">Service De Neurologie CHUO<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P125 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Sante holistique et pr\u00e9vention<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">N. Bekada &#8211; <\/span><\/strong><span style=\"font-size:12px;color:black;\">groupe de recherche en sciences sociales et sant\u00e9 GRAS Oran<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:3.75pt;font-size:11.0pt;font-family:'Calibri',sans-serif;line-height:normal;\"><strong><span style=\"font-size:19px;color:black;\">P126 &#8211; <\/span><\/strong><strong><span style=\"font-size:16px;color:black;\">Study of the place and scientific importance of biophysics in neurology: What is neurobiophysics?<br \/> <\/span><\/strong><strong><span style=\"font-size:13px;color:#002060;\">M. Boukabcha <\/span><\/strong><span style=\"font-size:12px;color:black;\"> Universit\u00e9 Hassiba BENBOUALI de Chlef<\/span><\/p>\n<p style=\"margin-top:12.0pt;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;font-size:11.0pt;font-family:'Calibri',sans-serif;\"><span style=\"font-size:16px;\"> <\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"class_list":["post-517","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/pages\/517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/comments?post=517"}],"version-history":[{"count":4,"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/pages\/517\/revisions"}],"predecessor-version":[{"id":523,"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/pages\/517\/revisions\/523"}],"wp:attachment":[{"href":"https:\/\/saneuro-dz.com\/index.php\/wp-json\/wp\/v2\/media?parent=517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}